Xbrane Biopharma

Major Shareholding Notification • Dec 6, 2023

Issuer Xbrane Biopharma AB

Holder

Avanza Bank Holding AB för Försäkringsaktiebolaget Avanza Pension

Instrument
Instrument	Aktier

Before the transaction
Shares	Data not given Data not given
Voting rights
Transaction
Reason for major shareholding notification Sell
Date	05/12/2023
Limit for number of shares	5 %
Limit for number of votes	5 %
After the transaction
Quantity
Shares	1,477,011
Directly held voting rights	0
Indirectly held voting rights	1,477,011
Percentage
Directly held shares	4.95469 %
Directly held voting rights	0 %
Indirectly held voting rights	4.95469 %

Resulting distribution of total holdings

	Percentage of voting rights:	Number of underlying shares:
Shares	4.95469 %	1,477,011
Instruments - FITA Ch. 4, section 2, first paragraph, line 2
Instruments - FITA Ch. 4, section 2, first paragraph, line 3
- Physically settled
- Cash settled	0.47669 %	142,103
Total	5.43138 %	1,619,114

Group total holdings

Voting rights 1,619,114 Percentage of voting rights 5.43138

Notes (other relevant informations according to law)

Aktierna, samt övriga instrument enligt LHF 4 kap, 2§ första stycket 1 och finansiella instrument enligt LHF 4 kap. 2§ första stycket 3 innehas av Försäkringsaktiebolaget Avanza Pension som är ett helägt dotterbolag till Avanza Bank Holding AB (publ). Det är försäkringskunder som via depåfullmakt har avyttrat de aktuella aktierna.

Published

06/12/2023 13:12

Contact

Name Marie Andersson

Email marie.andersson@avanza.se

*Source of information has chosen not to submit the data

rapportering@fi.se Tfn 08-408 980 37 Fax 08-24 39 25